15,490 Amrize Ltd $AMRZ Shares Sold by Murphy Pohlad Asset Management LLC

Murphy Pohlad Asset Management LLC decreased its position in shares of Amrize Ltd (NYSE:AMRZ) by 25.4% in the 3rd quarter, according to the company in its most recent Form 13F filing with the SEC. The firm owned 45,515 shares of the company’s stock after selling 15,490 shares during the quarter. Murphy Pohlad Asset Management LLC’s holdings in Amrize were worth $1,702,000 as of its most recent filing with the SEC.

Several other institutional investors have also modified their holdings of AMRZ. National Pension Service boosted its stake in Amrize by 7.5% during the 2nd quarter. National Pension Service now owns 1,493,022 shares of the company’s stock valued at $79,578,000 after purchasing an additional 103,962 shares during the period. Ancora Advisors LLC grew its position in Amrize by 22.9% in the 2nd quarter. Ancora Advisors LLC now owns 283,522 shares of the company’s stock worth $15,112,000 after purchasing an additional 52,759 shares during the last quarter. Engle Capital Management L.P. acquired a new stake in shares of Amrize in the first quarter valued at approximately $3,742,000. Renaissance Technologies LLC increased its stake in shares of Amrize by 10.4% in the first quarter. Renaissance Technologies LLC now owns 1,956,600 shares of the company’s stock valued at $109,609,000 after purchasing an additional 183,900 shares during the period. Finally, Punch & Associates Investment Management Inc. acquired a new stake in shares of Amrize in the first quarter valued at approximately $8,864,000.

Amrize Price Performance

AMRZ stock traded up $0.01 during trading on Friday, hitting $39.45. The company had a trading volume of 4,678,585 shares, compared to its average volume of 3,308,936. The firm has a market capitalization of $21.82 billion, a price-to-earnings ratio of 18.18, a P/E/G ratio of 1.40 and a beta of 0.20. The business has a 50 day moving average of $40.16 and a 200 day moving average of $48.28. Amrize Ltd has a fifty-two week low of $35.78 and a fifty-two week high of $65.94. The company has a current ratio of 1.10, a quick ratio of 0.73 and a debt-to-equity ratio of 0.33.

Amrize (NYSE:AMRZ) last released its earnings results on Thursday, August 6th. The company reported $0.88 EPS for the quarter, missing the consensus estimate of $0.92 by ($0.04). The company had revenue of $3.49 billion for the quarter. Amrize had a net margin of 9.89% and a return on equity of 10.22%. As a group, research analysts predict that Amrize Ltd will post 2.44 earnings per share for the current year.

Amrize Announces Dividend

The business also recently disclosed a dividend, which was paid on Wednesday, August 26th. Stockholders of record on Tuesday, August 18th were issued a $0.11 dividend. The ex-dividend date was Tuesday, August 18th. Amrize’s dividend payout ratio (DPR) is 5.07%.

Analyst Ratings Changes

A number of research firms have recently weighed in on AMRZ. Sanford C. Bernstein reaffirmed an “outperform” rating and set a $60.00 price target on shares of Amrize in a report on Monday, September 21st. Citigroup decreased their price objective on Amrize from $58.00 to $50.00 and set a “buy” rating for the company in a report on Friday, October 2nd. Bank of America reissued an “underperform” rating and issued a $40.00 price objective (down from $50.00) on shares of Amrize in a report on Wednesday, September 2nd. Deutsche Bank Aktiengesellschaft lowered their target price on Amrize from $64.00 to $56.00 and set a “buy” rating on the stock in a research report on Wednesday, September 23rd. Finally, Truist Financial cut their target price on Amrize from $48.00 to $35.00 and set a “hold” rating on the stock in a research note on Monday, October 5th. Eight analysts have rated the stock with a Buy rating, seven have assigned a Hold rating and four have issued a Sell rating to the stock. According to MarketBeat.com, the company has an average rating of “Hold” and a consensus price target of $49.12.

Insiders Place Their Bets

In other news, Director Jacques Sanche bought 4,150 shares of the company’s stock in a transaction that occurred on Wednesday, August 26th. The shares were purchased at an average price of $45.02 per share, with a total value of $186,833.00. Following the completion of the acquisition, the director directly owned 9,766 shares in the company, valued at approximately $439,665.32. This trade represents a 73.90% increase in their ownership of the stock. The purchase was disclosed in a legal filing with the Securities & Exchange Commission, which is available through the SEC website. Also, CFO Baris Oran bought 3,000 shares of the business’s stock in a transaction on Tuesday, August 11th. The stock was purchased at an average price of $47.38 per share, with a total value of $142,140.00. Following the completion of the transaction, the chief financial officer directly owned 3,000 shares of the company’s stock, valued at $142,140. This trade represents a ∞ increase in their ownership of the stock. The SEC filing for this purchase provides additional information. Over the last ninety days, insiders purchased 48,983 shares of company stock valued at $2,158,755. 0.54% of the stock is currently owned by insiders.

Amrize Profile

Amrize is a North American building-solutions company that supplies materials and products used in residential, commercial and infrastructure construction. Its portfolio includes cement, aggregates, ready-mix concrete, asphalt, roofing systems and other building products.

The company serves customers across the United States and Canada through a network of production facilities, distribution locations and related operations. Its products support applications ranging from roads, bridges and other public infrastructure to commercial buildings and residential construction.

Amrize was formed through the separation of Holcim’s North American business and began trading independently on the New York Stock Exchange under the symbol AMRZ in 2025.